- Filed
- May 12, 2015 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2015 · Mar 31, 2015 | 0 sh |
| Capex | Q1 2015 · Mar 31, 2015 | $6.15M |
| Capex | Q1 2015 · Mar 31, 2014 | $10.58M |
| Long Term Debt | Q1 2015 · Mar 31, 2015 | $684.29M |
| Long Term Debt | Q1 2015 · Dec 31, 2014 | $685M |
| Cash And Equivalents | Q1 2015 · Mar 31, 2015 | $33.6M |
| Cash And Equivalents | Q1 2015 · Dec 31, 2014 | $44.47M |
| Cash And Equivalents | Q1 2015 · Mar 31, 2014 | $38.55M |
| Cash And Equivalents | Q1 2015 · Dec 31, 2013 | $76.62M |
| Stockholders Equity | Q1 2015 · Mar 31, 2015 | $205.96M |
| Stockholders Equity | Q1 2015 · Dec 31, 2014 | $225.58M |
| Stockholders Equity | Q1 2015 · Mar 31, 2014 | $288.46M |
| Stockholders Equity | Q1 2015 · Dec 31, 2013 | $295.78M |
| Current Liabilities | Q1 2015 · Mar 31, 2015 | $264.72M |
| Current Liabilities | Q1 2015 · Dec 31, 2014 | $270.82M |
| Total Liabilities | Q1 2015 · Mar 31, 2015 | $1.12B |
| Total Liabilities | Q1 2015 · Dec 31, 2014 | $1.13B |
| Current Assets | Q1 2015 · Mar 31, 2015 | $536.5M |
| Current Assets | Q1 2015 · Dec 31, 2014 | $559.9M |
| Total Assets | Q1 2015 · Mar 31, 2015 | $1.32B |
| Total Assets | Q1 2015 · Dec 31, 2014 | $1.36B |
| Sga Expense | Q1 2015 · Mar 31, 2015 | $16.96M |
| Sga Expense restated | Q1 2015 · Mar 31, 2014 | $18.16M |
| Net Income | Q1 2015 · Mar 31, 2015 | −$12.27M |
| Net Income | Q1 2015 · Mar 31, 2014 | −$12.54M |
| Operating Income | Q1 2015 · Mar 31, 2015 | −$4.78M |
| Operating Income | Q1 2015 · Mar 31, 2014 | $4.75M |
| Gross Profit | Q1 2015 · Mar 31, 2015 | $18.02M |
| Gross Profit restated | Q1 2015 · Mar 31, 2014 | $32.57M |
| Cost Of Revenue | Q1 2015 · Mar 31, 2015 | $227.52M |
| Cost Of Revenue restated | Q1 2015 · Mar 31, 2014 | $219.06M |
| Revenue | Q1 2015 · Mar 31, 2015 | $245.54M |
| Revenue | Q1 2015 · Mar 31, 2014 | $251.62M |